BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 1111831)

  • 1. Cholinergic-dopaminergic interaction in the striatum: the effect of 6-hydroxydopamine or pimozide treatment on the increased striatal acetylcholine levels induced by apomorphine, piribedil and d-amphetamine.
    Ladinsky H; Consolo S; Bianchi S; Samanin R; Ghezzi D
    Brain Res; 1975 Feb; 84(2):221-6. PubMed ID: 1111831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase in striatal acetylcholine by picrotoxin in the rat: evidence for a gabergic-dopaminergic-cholinergic link.
    Ladinsky H; Consolo S; Bianchi S; Jori A
    Brain Res; 1976 May; 108(2):351-61. PubMed ID: 945112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine.
    Baud P; Arbilla S; Cantrill RC; Scatton B; Langer SZ
    J Pharmacol Exp Ther; 1985 Oct; 235(1):220-9. PubMed ID: 3930699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for multiple dopamine receptors involved in the modulation of acetylcholine release in the striatum.
    Hársing LG; Vizi ES
    Pol J Pharmacol Pharm; 1985; 37(3):383-96. PubMed ID: 2866504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of dopaminergic receptor agonists and antagonists on the activity of the neo-striatal cholinergic system.
    Guyenet PG; Javory AF; Beaujouan JC; Rossier BJ; Glowinski J
    Brain Res; 1975 Feb; 84(2):227-44. PubMed ID: 234276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrastriatal dopaminergic grafts restore inhibitory control over striatal cholinergic neurons.
    Herman JP; Lupp A; Abrous N; Le Moal M; Hertting G; Jackisch R
    Exp Brain Res; 1988; 73(2):236-48. PubMed ID: 3145893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decrease in rat striatal acetylcholine levels by some direct- and indirect-acting dopaminergic antagonists.
    Consolo S; Ladinsky H; Bianchi S
    Eur J Pharmacol; 1975; 33(2):345-51. PubMed ID: 1183479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopaminergic-cholinergic interaction in the striatum: studies with piribedil.
    Consolo S; Fanelli R; Garattini S; Ghezzi D; Jori A; Ladinsky H; Marc V; Samanin R
    Adv Neurol; 1975; 9():257-72. PubMed ID: 1146657
    [No Abstract]   [Full Text] [Related]  

  • 9. Lack of effect of intraventricular 6-hydroxydopamine pretreatment on rat striatal cholinergic parameters.
    Consolo S; Ladinsky H; Peri G; Samanin R; Ghezzi D
    Brain Res; 1974 Sep; 78(2):327-30. PubMed ID: 4852633
    [No Abstract]   [Full Text] [Related]  

  • 10. D-1 receptor-linked mechanism modulates cholinergic neurotransmission in rat striatum.
    Consolo S; Wu CF; Fusi R
    J Pharmacol Exp Ther; 1987 Jul; 242(1):300-5. PubMed ID: 2886638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apparent lack of a dopaminergic-cholinergic link in the rat nucleus accumbens septi-tuberculum olfactorium.
    Consolo S; Ladinsky H; Bianchi S; Ghezzi D
    Brain Res; 1977 Oct; 135(2):255-63. PubMed ID: 922475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of the locomotor activity effects of apomorphine and the "atypical dopamine agonists" (piribedil and S3608).
    Offermeier J; van Rooyen JM
    Life Sci; 1986 Mar; 38(10):895-903. PubMed ID: 3081774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine released from mesencephalic transplants restores modulation of striatal acetylcholine release after neonatal 6-hydroxydopamine: an in vitro analysis.
    Carder RK; Jackson D; Morris HJ; Lund RD; Zigmond MJ
    Exp Neurol; 1989 Sep; 105(3):251-9. PubMed ID: 2569987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of permanently charged and uncharged dopaminergic agonists on the potassium-induced release of [3H]acetylcholine from striatal slices.
    Sabol B; Boldry R; Farooqui T; Chang YA; Miller D; Uretsky N
    Biochem Pharmacol; 1987 May; 36(10):1679-85. PubMed ID: 3109428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of striatal acetylcholine concentration by dopamine receptor agonists and antagonists.
    Sethy VH; VAN Woert MH
    Res Commun Chem Pathol Pharmacol; 1974 May; 8(1):13-28. PubMed ID: 4847901
    [No Abstract]   [Full Text] [Related]  

  • 16. Increase in striatal acetylcholine levels in vivo by piribedil a new dopamine receptor stimulant.
    Ladinsky H; Consolo S; Garattini S
    Life Sci; 1974 Apr; 14(7):1251-60. PubMed ID: 4823638
    [No Abstract]   [Full Text] [Related]  

  • 17. Striatal cholinergic function reflects differences in D-2 dopaminergic receptor activation.
    Forloni G; Bidzinski A; Fusi R; Ladinsky H; Consolo S
    Life Sci; 1987 Oct; 41(14):1717-23. PubMed ID: 2958667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apomorphine and amphetamine stereotypy after 6-hydroxydopamine lesions of the substantia nigra.
    Price MT; Fibiger HC
    Eur J Pharmacol; 1974 Dec; 29(2):249-52. PubMed ID: 4613562
    [No Abstract]   [Full Text] [Related]  

  • 19. Regulation of striatal acetylcholine concentration by dopamine receptors.
    Sethy VH; Van Woert MH
    Nature; 1974 Oct; 251(5475):529-30. PubMed ID: 4421728
    [No Abstract]   [Full Text] [Related]  

  • 20. In vivo inhibition of striatal acetycholine turnover by L-DOPA, apomophine and (plus)-amphetamine.
    Trabucchi M; Cheney DL; Racagni G; Costa E
    Brain Res; 1975 Feb; 85(1):130-4. PubMed ID: 1109691
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.